Thermal Intravesical Chemotherapy Reduce Recurrence Rate for Non-muscle Invasive Bladder Cancer Patients: A Meta-Analysis

Background: Non-muscle invasive bladder cancer accounts for nearly 80% of newly diagnosed bladder cancer cases, which often recur and progress. This meta-analysis was evaluated by the adverse events and recurrence rate of thermal intravesical chemotherapy vs. normal temperature intravesical chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kang, Zhu, Jun, Song, Yu-Xuan, Wang, Xiao, Zhou, Ke-Chong, Lu, Yi, Liu, Xiao-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015071/
https://www.ncbi.nlm.nih.gov/pubmed/32117709
http://dx.doi.org/10.3389/fonc.2020.00029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015071/
https://www.ncbi.nlm.nih.gov/pubmed/32117709
http://dx.doi.org/10.3389/fonc.2020.00029

Ejemplares similares